Corteva (NYSE:CTVA) Reaches New 1-Year High – Should You Buy?

Shares of Corteva, Inc. (NYSE:CTVA) reached a new 52-week high during trading on Monday . The stock traded as high as $83.44 and last traded at $83.1210, with a volume of 304889 shares. The stock had previously closed at $81.99.

Analyst Ratings Changes

Several equities research analysts have issued reports on CTVA shares. Citigroup boosted their price objective on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Oppenheimer set a $86.00 target price on shares of Corteva in a research report on Thursday, February 5th. Jefferies Financial Group boosted their price target on Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Finally, Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Fourteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, Corteva currently has an average rating of “Moderate Buy” and a consensus target price of $83.45.

Corteva Trading Up 0.9%

The stock has a market capitalization of $56.19 billion, a P/E ratio of 52.97, a P/E/G ratio of 2.83 and a beta of 0.72. The stock’s 50 day moving average price is $76.82 and its 200-day moving average price is $69.78. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. Corteva’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva’s dividend payout ratio is 45.57%.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.15% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in CTVA. Activest Wealth Management grew its stake in shares of Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares during the last quarter. JPL Wealth Management LLC purchased a new position in shares of Corteva in the 3rd quarter valued at approximately $25,000. True Wealth Design LLC boosted its stake in Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares in the last quarter. Total Investment Management Inc. acquired a new stake in Corteva in the 2nd quarter worth approximately $27,000. Finally, Garton & Associates Financial Advisors LLC purchased a new stake in Corteva during the 4th quarter worth approximately $27,000. 81.54% of the stock is owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.